These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2448885)

  • 1. DHF characterized by acute type DIC with increased vascular permeability.
    Funahara Y; Sumarmo ; Shirahata A; Setiabudy-Dharma R
    Southeast Asian J Trop Med Public Health; 1987 Sep; 18(3):346-50. PubMed ID: 2448885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features of DIC in dengue hemorrhagic fever.
    Funahara Y; Sumarmo ; Wirawan R
    Bibl Haematol; 1983; (49):201-11. PubMed ID: 6667246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haematology in dengue and dengue haemorrhagic fever.
    Srichaikul T; Nimmannitya S
    Baillieres Best Pract Res Clin Haematol; 2000 Jun; 13(2):261-76. PubMed ID: 10942625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.
    Wada H; Yamamuro M; Inoue A; Shiku H; Sakuragawa N; Redl H; Peer G; Taylor FB
    Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood coagulation and fibrinolytic factors as well as their inhibitors in trauma.
    Blombäck M; Eklund J; Hellgren M; Lagerkranser M; Swedenborg J
    Scand J Clin Lab Invest Suppl; 1985; 178():15-23. PubMed ID: 3867116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever).
    Lee M; Kim BK; Kim S; Park S; Han JS; Kim ST; Lee JS
    Rev Infect Dis; 1989; 11 Suppl 4():S877-83. PubMed ID: 2568677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
    Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun. Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Shiku H
    Thromb Haemost; 1995 Sep; 74(3):848-52. PubMed ID: 8571309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of heparin and antiplasmin on platelet level in dengue haemorrhagic fever.
    Uttayopas C
    Southeast Asian J Trop Med Public Health; 1987 Sep; 18(3):380-2. PubMed ID: 3433167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Model of disseminated intravascular coagulation].
    Fedorov NA; Gorbunova NA; Balakina TA; Kolpikov VN
    Biull Eksp Biol Med; 1978; 86(7):116-20. PubMed ID: 678642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of factor XII, prekallikrein and kallikrein inhibitory capacity in patients with laboratory signs of DIC.
    Egberg N; Hellgren M
    Scand J Clin Lab Invest Suppl; 1985; 178():25-9. PubMed ID: 3867118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation.
    Aibiki M; Fukuoka N; Umakoshi K; Ohtsubo S; Kikuchi S
    Shock; 2007 Feb; 27(2):139-44. PubMed ID: 17224787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated tumour necrosis factor in dengue fever and dengue haemorrhagic fever.
    Vitarana T; de Silva H; Withana N; Gunasekera C
    Ceylon Med J; 1991 Jun; 36(2):63-5. PubMed ID: 1913986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemostatic abnormalities in DIC].
    Wada H
    Rinsho Byori; 2002 Aug; 50(8):768-72. PubMed ID: 12373812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic derangement in dengue haemorrhagic fever.
    Isarangkura PB; Pongpanich B; Pintadit P; Phanichyakarn P; Valyasevi A
    Southeast Asian J Trop Med Public Health; 1987 Sep; 18(3):331-9. PubMed ID: 3433165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.
    Kahle LH; Avvisati G; Lamping RJ; Moretti T; Mandelli F; ten Cate JW
    Scand J Clin Lab Invest Suppl; 1985; 178():75-80. PubMed ID: 2418490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the coagulation cascade in patients with leptospirosis.
    Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
    Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin and other DIC-related variables in patients with moderately severe infections receiving cryoprecipitate.
    Brodin B; Hesselvik F; Blombäck M; Cedergren B; Lieden G; Maller R; Strindberg J
    Scand J Clin Lab Invest Suppl; 1985; 178():57-65. PubMed ID: 3937219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.